Low levels of C-peptide have clinical significance for established Type 1 diabetes (Q34484912)

2 August 2017

title

Low levels of C-peptide have clinical significance for established Type 1 diabetes (English)

1 reference

2 August 2017

0 references

W M Kuhtreiber

1

1 reference

2 August 2017

S L L Washer

2

1 reference

2 August 2017

E Hsu

3

1 reference

2 August 2017

M Zhao

4

1 reference

2 August 2017

P Reinhold

5

1 reference

2 August 2017

D Burger

6

1 reference

2 August 2017

H Zheng

7

1 reference

2 August 2017

D L Faustman

8

1 reference

2 August 2017

publication date

14 July 2015

1 reference

2 August 2017

1 reference

2 August 2017

volume

32

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

1346-1353

1 reference

Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

"Prediction is very hard, especially about the future": new biomarkers for type 2 diabetes?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-scor

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Alternative markers of hyperglycemia and risk of diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Serum 1,5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Complications of type 1 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

The case for blood glucose control

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Type I diabetes mellitus. A chronic autoimmune disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4578991

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

6 July 2018

1 reference

Why were we wrong for so long? The pancreas of type 1 diabetic patients commonly functions for decades

21 January 2018

1 reference

Decline of C-peptide during the first year after diagnosis of Type 1 diabetes in children and adolescents

21 January 2018

1 reference

Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study

21 January 2018

1 reference

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

21 January 2018

1 reference

Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up

21 January 2018

1 reference

Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes.

21 January 2018

1 reference

Executive summary: Standards of medical care in diabetes--2014

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26172028

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence of residual B-cell function related to age at onset and genetic profile in newly diagnosed type I diabetics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26172028

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26172028

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/DME.12850

1 reference

2 August 2017

1 reference

2 August 2017

1 reference